| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |